Journal of Clinical Endocrinology & Metabolism, Vol 79, 750-755, Copyright © 1994 by Endocrine Society

ARTICLES

An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome

A Shenker, LS Weinstein, DE Sweet and AM Spiegel
Molecular Pathophysiology Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.

McCune-Albright syndrome (MAS) is a sporadic disease characterized by polyostotic fibrous dysplasia, cafe-au-lait spots, and multiple endocrinopathies. The etiology of fibrous dysplasia is unknown. Activating mutations of codon 201 in the gene encoding the alpha- subunit of Gs, the G-protein that stimulates adenylyl cyclase, have been found in all affected MAS tissues that have been studied. Initial attempts to amplify DNA from decalcified paraffin-embedded bone specimens from MAS patients were unsuccessful. Therefore, we analyzed DNA from frozen surgical bone specimens from five MAS patients using polymerase chain reaction and allele-specific oligonucleotide hybridization. Most of the cells in four specimens of dysplastic bone contained a heterozygous mutation encoding substitution of Arg201 of Gs alpha with His, but the mutation was barely detectable in peripheral blood specimens from the patients. Only a small amount of mutant allele was detected in a specimen of normal cortical bone from the fifth patient, although this patient had a high proportion of mutation in other, affected tissues. The mosaic distribution of mutant alleles is consistent with an embryological somatic cell mutation of the Gs alpha gene in MAS. The presence of an activating mutation of Gs alpha in osteoblastic progenitor cells may cause them to exhibit increased proliferation and abnormal differentiation, thereby producing the lesions of fibrous dysplasia.

This article has been cited by other articles:

				E. Pavel, K. Nadella, W. H. Towns II, and L. S. Kirschner Mutation of Prkar1a Causes Osteoblast Neoplasia Driven by Dysregulation of Protein Kinase A Mol. Endocrinol., February 1, 2008; 22(2): 430 - 440. [Abstract] [Full Text] [PDF]

				V. Lavoue, K. Morcel, P. Bouchard, C. Sultan, C. Massart, J.-Y. Grall, S. Lumbroso, and M.-C. Laurent Restoration of ovulation after unilateral ovariectomy in a woman with McCune Albright syndrome: a case report Eur. J. Endocrinol., January 1, 2008; 158(1): 131 - 134. [Abstract] [Full Text] [PDF]

				S. Michienzi, N. Cherman, K. Holmbeck, A. Funari, M. T. Collins, P. Bianco, P. G. Robey, and M. Riminucci GNAS transcripts in skeletal progenitors: evidence for random asymmetric allelic expression of Gs{alpha} Hum. Mol. Genet., August 15, 2007; 16(16): 1921 - 1930. [Abstract] [Full Text] [PDF]

				E. B Trarbach, M. T M Baptista, H. M Garmes, and C. Hackel Molecular analysis of KAL-1, GnRH-R, NELF and EBF2 genes in a series of Kallmann syndrome and normosmic hypogonadotropic hypogonadism patients J. Endocrinol., December 1, 2005; 187(3): 361 - 368. [Abstract] [Full Text] [PDF]

				L. S. Weinstein, J. Liu, A. Sakamoto, T. Xie, and M. Chen Minireview: GNAS: Normal and Abnormal Functions Endocrinology, December 1, 2004; 145(12): 5459 - 5464. [Abstract] [Full Text] [PDF]

				S. Lumbroso, F. Paris, and C. Sultan Activating Gs{alpha} Mutations: Analysis of 113 Patients with Signs of McCune-Albright Syndrome--A European Collaborative Study J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2107 - 2113. [Abstract] [Full Text] [PDF]

				A. Karadag, M. Riminucci, P. Bianco, N. Cherman, S. A. Kuznetsov, N. Nguyen, M. T. Collins, P. G. Robey, and L. W. Fisher A novel technique based on a PNA hybridization probe and FRET principle for quantification of mutant genotype in fibrous dysplasia/McCune-Albright syndrome Nucleic Acids Res., April 19, 2004; 32(7): e63 - e63. [Abstract] [Full Text] [PDF]

				J. S. Lee, E. FitzGibbon, J. A. Butman, C. R. Dufresne, H. Kushner, S. Wientroub, P. G. Robey, and M. T. Collins Normal Vision despite Narrowing of the Optic Canal in Fibrous Dysplasia N. Engl. J. Med., November 21, 2002; 347(21): 1670 - 1676. [Abstract] [Full Text] [PDF]

				X.-P. Huang, X. Song, H.-Y. Wang, and C. C. Malbon Targeted expression of activated Q227L Galpha s in vivo Am J Physiol Cell Physiol, August 1, 2002; 283(2): C386 - C395. [Abstract] [Full Text] [PDF]

				L. S. Weinstein, S. Yu, D. R. Warner, and J. Liu Endocrine Manifestations of Stimulatory G Protein {alpha}-Subunit Mutations and the Role of Genomic Imprinting Endocr. Rev., October 1, 2001; 22(5): 675 - 705. [Abstract] [Full Text] [PDF]

				A. Sakamoto, Y. Oda, Y. Iwamoto, and M. Tsuneyoshi A Comparative Study of Fibrous Dysplasia and Osteofibrous Dysplasia with Regard to GS{alpha} Mutation at the Arg201 Codon: Polymerase Chain Reaction-Restriction Fragment Length Polymorphism Analysis of Paraffin-Embedded Tissues J. Mol. Diagn., May 1, 2000; 2(2): 67 - 72. [Abstract] [Full Text]

				A. Wang, J. A. Martin, L. A. Lembke, and R. J. Midura Reversible Suppression of in Vitro Biomineralization by Activation of Protein Kinase A J. Biol. Chem., April 6, 2000; 275(15): 11082 - 11091. [Abstract] [Full Text] [PDF]

				P.-M. Holterhus, H. T. Bruggenwirth, O. Hiort, A. Kleinkauf-Houcken, K. Kruse, G. H. G. Sinnecker, and A. O. Brinkmann Mosaicism due to a Somatic Mutation of the Androgen Receptor Gene Determines Phenotype in Androgen Insensitivity Syndrome J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3584 - 3589. [Abstract] [Full Text] [PDF]

				F. R. DIETZ and K. D. MATHEWS Current Concepts Review - Update on the Genetic Bases of Disorders with Orthopaedic Manifestations J. Bone Joint Surg. Am., October 1, 1996; 78(10): 1583 - 98. [Full Text]

				G. A. Candeliere, F. H. Glorieux, J. Prud'homme, and R. St.-Arnaud Increased Expression of the c-fos Proto-Oncogene in Bone from Patients with Fibrous Dysplasia N. Engl. J. Med., June 8, 1995; 332(23): 1546 - 1551. [Abstract] [Full Text] [PDF]